Trial Profile
A multicentre, double blind, parallel group, phase IIa clinical trial to assess the efficacy and safety of Cpn10 administered as twice weekly intravenous injections in subjects with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors CBio
- 29 Aug 2011 Actual initiation date (Aug 2005) added as reported by Australian New Zealand Clinical Trials Registry.
- 29 Aug 2011 Additional trial identifiers (ACTRN12606000041550, 001022) identified, inclusion and exclusion criteria amended and addititional trial centers identified as reported by Australian New Zealand Clinical Trials Registry.
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000041550).